Medizinische Universität Graz - Research portal
Jesche-Chromecki Johanna |
** = Publications listed in SCI/SSCI/Pubmed
2019
Full paper/article (Journal)
** Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31.
Doi: 10.5173/ceju.2018.1858
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Full paper/article (Journal)
** Becker, A; Hickmann, D; Hansen, J; Meyer, C; Rink, M; Schmid, M; Eichelberg, C; Strini, K; Chromecki, T; Jesche, J; Regier, M; Randazzo, M; Tilki, D; Ahyai, S; Dahlem, R; Fisch, M; Zigeuner, R; Chun, FK
Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Eur J Surg Oncol. 2016; 42(3):419-25
Doi: 10.1016/j.ejso.2015.09.023
Web of Science
PubMed
FullText
FullText_MUG
** Meyer, C; Hansen, J; Becker, A; Schmid, M; Pradel, L; Strini, K; Chromecki, T; Jesche-Chromecki, J; Fisch, M; Zigeuner, R; Chun, FK
The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.
Urol Int. 2016; 96(3):330-336
Doi: 10.1159/000442215
Web of Science
PubMed
FullText
FullText_MUG
2015
Abstract (Journal)
** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M
Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL.
Doi: 10.1200/jco.2015.33.7_suppl.513
[Poster]
Web of Science
FullText
FullText_MUG
2014
Full paper/article (Journal)
** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M
Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048
Doi: 10.1016/j.urolonc.2014.04.001
Web of Science
PubMed
FullText
FullText_MUG
2013
Full paper/article (Journal)
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Hoefler, G; Pummer, K; Zigeuner, R
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Histopathology. 2013; 62(2):237-246
Doi: 10.1111/his.12001
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Pummer, K; Zigeuner, R
Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
BJU Int. 2013; 111(4 Pt B):E191-E195
Doi: 10.1111/j.1464-410X.2012.11584.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Full paper/article (Journal)
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839
Doi: 10.1016/j.juro.2011.10.155
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R
Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724
Doi: 10.1136/jclinpath-2012-200797
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival.
Int Urol Nephrol. 2012; 44(4):997-1004
Doi: 10.1007/s11255-012-0165-5
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R
Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Am J Clin Pathol. 2012; 137(2): 283-289.
Doi: 10.1309/AJCPLBK9L9KDYQZP
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Becker, A; Hansen, J; Eichelberg, C; Heuer, R; Meyer, CP; Adam, M; Kampel-Kettner, K; Kainz, MC; Chromecki, T; Jesche, J; Zigeuner, R; Chun, KHF
A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe
EUR UROL SUPPL. 2012; 11(1): E1021-U136.
[Poster]
Web of Science
2011
Full paper/article (Journal)
** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R
External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
J Urol. 2011; 186(5):1773-1777
Doi: 10.1016/j.juro.2011.07.034
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar